HPV – genetic test (16 genotypes) qualitatively
Material: Other material
Price of the study: 180 PLN
Waiting time: result after 10 working days
Booking:
Price of the study: 180 PLN
Waiting time: result after 10 working days
Booking:
- Advance appointment booking required.
Preparation for the study
General
- Moisturizers, intimate hygiene products, contraceptive gels (with the exception of a gel called Advantage - S ® Bioadhesive Contraceptive Gel) do not interfere with the test.
Detailed for women
- The test should not be performed:
- during menstruation,
- during treatment with antibiotics,
- during treatment with vaginal preparations (globules, creams),
- when irrigations are used,
- within 48 hours after the last sexual intercourse.
On the day of the test, the genital area should be washed without using soap or intimate hygiene gels.
If treatment has been used, a 3-5 day break is recommended between the end of treatment
and the performance of the test. - The test material in women is a cervical swab.
Detailed for men
- The test material is a swab from the genital groove.
If treatment was used, it is recommended that there be a 3-5 day break between the end of treatment,
and the performance of the test.
Before taking the material for the test:
- do not use antibiotics, steroids, medicated creams,
- do not wash genitals for at least 48 hours (72 hours recommended to increase the effectiveness of virus detection),
- do not have sex for at least 24 hours.
Important
Samples brought from outside are not accepted for testing.
It is necessary to attach a document-"Referral and consent for genetic testing(HPV,Chlamydia trachomatis) LUXMED. Available in the Patient's Essentials-Downloadable forms.
It is necessary to attach a document-"Referral and consent for genetic testing(HPV,Chlamydia trachomatis) LUXMED. Available in the Patient's Essentials-Downloadable forms.
Description
The test is intended to detect the presence of HPV DNA and is a qualitative test.
The test detects the presence of two non-oncogenic types of the virus: 6 and 11, responsible for the development of condylomata acuminata (condyloma acuminata) and oncogenic types of the HPV virus: type 16 and 18 and a total of 12 other genotypes from the group with high oncogenic potential, i.e.: 31,33,3539,45,51,52,56,58,59,66,68, without their genotyping. Which means that the detection of the presence of the HPV virus from this group (Other) is reported in the result as "DETECTED", without the possibility of indicating specifically which of these genotypes is present in the patient's material.
The test detects the presence of two non-oncogenic types of the virus: 6 and 11, responsible for the development of condylomata acuminata (condyloma acuminata) and oncogenic types of the HPV virus: type 16 and 18 and a total of 12 other genotypes from the group with high oncogenic potential, i.e.: 31,33,3539,45,51,52,56,58,59,66,68, without their genotyping. Which means that the detection of the presence of the HPV virus from this group (Other) is reported in the result as "DETECTED", without the possibility of indicating specifically which of these genotypes is present in the patient's material.
The test is performed by polymerase chain reaction( PCR) in real time ( Real Time PCR).
The performance of this test is recommended especially to exclude / confirm condylomata acuminata ( condylomata acuminata) and in couples planning offspring and pregnant women . In the case of pregnant women, detection of genotypes 6 and 11 may be an indication of
for delivery by cesarean section (risk of infection of the baby's respiratory tract during natural delivery).
Development and preparation of material (applies to contractors only)
959